Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis

Documenti analoghi

• Liquid chromatography–tandem mass spectrometry determination of bumetanide in human plasma and application to a clinical pharmacokinetic study
  di: Ganesan Padmini Tamilarasi, et al.
  Pubblicazione: (2024)
• Pharmacokinetic study of iptacopan and its two acyl glucuronide metabolites in monkey plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry
  di: Jingchu Li, et al.
  Pubblicazione: (2024)
• Quantitation of tazemetostat in human plasma using liquid chromatography–tandem mass spectrometry
  di: Marco Orleni, et al.
  Pubblicazione: (2024)
• Simultaneous determination of four fungicide residues in figs using liquid chromatography tandem mass spectrometry
  di: Feng Lan, et al.
  Pubblicazione: (2024)
• Identification of the metabolites of nimbolide in rat by liquid chromatography combined with quadrupole/orbitrap mass spectrometry
  di: Kun Li, et al.
  Pubblicazione: (2024)